News
-
-
PRESS RELEASE
Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month
Piramal Pharma Solutions and NP2 are set to complete the development phase of cyclophosphamide, addressing shortages and supply chain risks, ensuring patient access to cancer treatment in the U.S -
-
PRESS RELEASE
Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility
Ontario invests $1.7 million in Piramal Pharma's Aurora facility, enhancing healthcare innovation and creating job opportunities. Government supports life sciences sector growth -
-
PRESS RELEASE
Piramal Pharma Solutions Advances Sustainability Efforts with Solar Power Plant Addition at Morpeth, UK Site
Piramal Pharma Solutions enhances sustainability efforts by installing a 4.3 MWp solar power plant at UK site, reducing greenhouse gas emissions and showcasing commitment to renewable energy -
-
-
-